ReviewJournal of the Korean Society of Radiology2025
Abbreviated MRI-Based Surveillance Strategies for Early Hepatocellular Carcinoma Detection.
Review in Journal of the Korean Society of Radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Performance of GAAD and GALAD Biomarker Panels for HCC Detection in Patients with MASLD or ALD Cirrhosis.Cancers · 2025Article
- [Preface for the Special Issue on Liver Imaging in Focus].Journal of the Korean Society of Radiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although US has been widely used for hepatocellular carcinoma (HCC) surveillance, it exhibits limited sensitivity for detecting early-stage HCC. Abbreviated MRI (AMRI) has attracted attention as a superior alternative, offering higher sensitivity for early-stage HCC detection than US and reduced imaging time and cost compared to comprehensive contrast-enhanced MRI. AMRI focuses on essential sequences tailored for HCC detection, with three main strategies: gadoxetate disodium-enhanced hepatobiliary phase AMRI, dynamic contrast-enhanced AMRI, and non-contrast AMRI. In this review, we aim to highlight the technical considerations, performance, and strengths and limitations of each AMRI strategy as well as reporting strategies and recall practices. In addition, to maximize HCC surveillance efficacy using AMRI, a risk-adapted strategy tailored to different patient groups would be necessary, which we will also explore in this review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.